GE HealthCare Technologies

GEHC - GE HealthCare Technologies • Financials

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
19,552
3,045
-
7%
3
7,133
19%
6,938
2.3
1,987
-387
-478
1,600
-33
-41
3%
0.12%
12/2024
19,672
3,205
-
10%
4.3
8,446
24%
6,062
1.9
1,830
-401
-573
1,429
-93
-55
2.8%
0.15%
12/2025
20,625
3,341
-
10%
4.6
10,379
20%
5,491
1.6
1,857
-482
617
1,375
-242
-64
3.1%
0.17%